ArticleCureus2026
Extensive Cerebral Venous Sinus Thrombosis in a Young Male With Severe Hyperhomocysteinaemia: An Unusual Presentation With Early Diplopia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral venous sinus thrombosis (CVST) is a rare cause of stroke, particularly in young adults, and often presents with nonspecific symptoms that may delay diagnosis. Hyperhomocysteinaemia is a recognized but frequently overlooked prothrombotic risk factor. We report a case of a 25-year-old previously healthy male who presented with sudden-onset severe unilateral headache and projectile vomiting. Neuroimaging with magnetic resonance imaging and venography revealed extensive thrombosis involving the superior sagittal, left transverse, and left sigmoid sinuses with cortical veins involvement. Laboratory evaluation showed markedly elevated serum homocysteine levels, with no other identifiable risk factors. The patient was treated with therapeutic anticoagulation, osmotic agents, and vitamin supplementation for hyperhomocysteinaemia. During treatment, he developed early horizontal diplopia due to left abducens nerve palsy, attributed to evolving intracranial hypertension. Acetazolamide with Fresnel prism eye glasses led to stabilization and gradual improvement of symptoms. This case emphasizes the importance of evaluating metabolic risk factors such as hyperhomocysteinaemia in young patients with CVST and highlights the need for vigilant clinical monitoring for neurological deterioration even after initiation of appropriate therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.